ClinicalTrials.Veeva

Menu

Study on Complications, EfficAcy and Costs of Large Polypectomy (SCALP)

V

Valduce Hospital

Status

Unknown

Conditions

Polypectomy

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Colonoscopy has been shown to reduce the incidence and mortality of colorectal cancer, through the recognition and removal of pre-cancerous lesions, which in most cases evolve with a sequence that goes through formation of high-grade dysplasia (HGD).

The probability of HGD increases with the increase of the lesion of the polyp itself. Lesions> 2 cm are present in 1% of colonoscopy screening. The resection of these lesions presents a greater technical difficulty and consequently a decrease in the efficiency. The rate of incomplete resection reported in the literature reaches 10% while that of recurrence / residual adenoma 16.4 / 31.7%.

The aim of the study SCALP is to evaluate the incidence of complications, efficacy and cost of endoscopic resection of colic lesions> 2cm in a setting of clinical practice in an unselected population

Enrollment

1,000 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • adult patients undergoing large endoscopic polypectomy

Exclusion criteria

  • pregnancy
  • incapacity to give informed consent

Trial design

1,000 participants in 1 patient group

colonoscopy population

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems